✦ LIBER ✦

Meta-Analysis of GLP-1 Receptor Agonist Lixisenatide Use in Patients Insufficiently Controlled with Oral Antihyperglycemic Agents

✍ Scribed by Hramiak, Irene; Raccah, Denis; Ceriello, Antonio; Gourdy, Pierre; Sagnard, Luc; Lin, Jay; Rosenstock, Julio

Book ID: 121980703
Publisher: Canadian Diabetes Association
Year: 2013
Tongue: English
Weight: 153 KB
Volume: 37
Category: Article
ISSN: 1499-2671
DOI: 10.1016/j.jcjd.2013.08.109

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-Analysis of Randomized Controlled T

Meta-Analysis of Randomized Controlled Trials of Lixisenatide as Add On to Basal Insulin and/or Oral Antihyperglycemic Agents in Patients with Type 2 Diabetes Mellitus

✍ Goldenberg, Ronald M.; Puig-Domingo, Manuel; Fonseca, Vivian; Wang, Edward C.; L 📂 Article 📅 2013 🏛 Canadian Diabetes Association 🌐 English ⚖ 307 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)

✍ Y. Seino; K. W. Min; E. Niemoeller; A. Takami; on behalf of the EFC10887 GETGOAL 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 602 KB

Dose-dependent effects of the once-daily

Dose-dependent effects of the once-daily GLP-1 receptor agonist lixisenatide in patients with Type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled trial

✍ R. E. Ratner; J. Rosenstock; G. Boka; on behalf of the DRI6012 Study Investigato 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

Glucagon-like peptide-1 receptor agonist

Glucagon-like peptide-1 receptor agonists versus insulin in inadequately controlled patients with type 2 diabetes mellitus: a meta-analysis of clinical trials

✍ Y. Wang; L. Li; M. Yang; H. Liu; G. Boden; G. Yang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 692 KB